Search research articles
Contact Us
Filters
Showing results (11-20 of 63) with videos related to
Page
of 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 21, 2024
Nuclear Pharmacy Training in the Era of Theranostics: Toward Meeting the Needs of Nuclear Medicine Patients for Comprehensive Pharmaceutical Care
Isabelle Laverdière, Gilbert Matte, Martin Darveau, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 21, 2011
The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy
Jean-Mathieu Beauregard, Michael S Hofman, Grace Kong, et al.
Cancers
|
August 27, 2021
PSMA Theranostics: Current Landscape and Future Outlook
Hanbo Zhang, Stella Koumna, Frédéric Pouliot, et al.
Clinical Nuclear Medicine
|
October 14, 2022
Differential Detection of Hepatic Metastases on 68 Ga-DOTATATE PET/CT and 177 Lu-DOTATATE SPECT/CT
Hanan Zahed, Jean-Mathieu Beauregard, Gad Abikhzer, et al.
EJNMMI Physics
|
May 17, 2020
Impact of dead time on quantitative <sup>177</sup>Lu-SPECT (QSPECT) and kidney dosimetry during PRRT
Alessandro Desy, Guillaume F Bouvet, Andrea Frezza, et al.
Clinical Nuclear Medicine
|
June 9, 2015
Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas
Ioan-Andrei Iliuta, Jean-Mathieu Beauregard, Félix Couture, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 19, 2008
Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT
Jean-Mathieu Beauregard, Etienne Croteau, Naseem Ahmed, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
June 21, 2011
Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
Jean-Mathieu Beauregard, Michael S Hofman, Jucilene M Pereira, et al.
Physics in Medicine and Biology
|
July 10, 2019
Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a <sup>177</sup>Lu-DOTATATE patient study
Wei Zhao, Pedro Luis Esquinas, Andrea Frezza, et al.
EJNMMI Physics
|
August 17, 2022
Impact of the dead-time correction method on quantitative <sup>177</sup>Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy
Alessandro Desy, Guillaume F Bouvet, Nancy Lafrenière, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 63) with videos related to
Sort By:
Page
of 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 21, 2024
Nuclear Pharmacy Training in the Era of Theranostics: Toward Meeting the Needs of Nuclear Medicine Patients for Comprehensive Pharmaceutical Care
Isabelle Laverdière, Gilbert Matte, Martin Darveau, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 21, 2011
The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy
Jean-Mathieu Beauregard, Michael S Hofman, Grace Kong, et al.
Cancers
|
August 27, 2021
PSMA Theranostics: Current Landscape and Future Outlook
Hanbo Zhang, Stella Koumna, Frédéric Pouliot, et al.
Clinical Nuclear Medicine
|
October 14, 2022
Differential Detection of Hepatic Metastases on 68 Ga-DOTATATE PET/CT and 177 Lu-DOTATATE SPECT/CT
Hanan Zahed, Jean-Mathieu Beauregard, Gad Abikhzer, et al.
EJNMMI Physics
|
May 17, 2020
Impact of dead time on quantitative <sup>177</sup>Lu-SPECT (QSPECT) and kidney dosimetry during PRRT
Alessandro Desy, Guillaume F Bouvet, Andrea Frezza, et al.
Clinical Nuclear Medicine
|
June 9, 2015
Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas
Ioan-Andrei Iliuta, Jean-Mathieu Beauregard, Félix Couture, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 19, 2008
Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT
Jean-Mathieu Beauregard, Etienne Croteau, Naseem Ahmed, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
June 21, 2011
Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
Jean-Mathieu Beauregard, Michael S Hofman, Jucilene M Pereira, et al.
Physics in Medicine and Biology
|
July 10, 2019
Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a <sup>177</sup>Lu-DOTATATE patient study
Wei Zhao, Pedro Luis Esquinas, Andrea Frezza, et al.
EJNMMI Physics
|
August 17, 2022
Impact of the dead-time correction method on quantitative <sup>177</sup>Lu-SPECT (QSPECT) and dosimetry during radiopharmaceutical therapy
Alessandro Desy, Guillaume F Bouvet, Nancy Lafrenière, et al.
Page
of 7